The Presence of Small-Size Circulating Tumor Cells Predicts Worse Prognosis in Non–Small Cell Lung Cancer Patients

To the Editor.—Most non–small cell lung cancer (NSCLC) patients are diagnosed at advanced stages. The 5-year survival rate of patients with advanced lung cancer is less than 20%, which makes lung cancer the leading cause of cancer-related deaths worldwide. Thus, accurately predicting the prognosis of these patients is extremely important in clinics, and it could be a challenge for laboratories to determine a predictor of disease severity. In a recent issue of the Archives of Pathology & Laboratory Medicine, Sun et al1 aimed to find the association between circulating tumor cells, circulating tumor-derived endothelial cells and their subtypes, and the prognosis of NSCLC patients. Based on univariate and multivariate analysis, they found that small-size circulating tumor cells are a reliable prognostic indicator and a probable predictor of the severity of disease in NSCLC patients. However, in this letter, we raise some statistical concerns about this study that may change the results or conclusion.For the predictor logistic regression analysis in 2 previous studies, 10 outcomes for 1 variable were demanded as a basic statistical rule.2,3 However, in the study by Sun et al,1 Table 3 analyzed 12 variables, demanding 120 death cases, for the univariate analysis of survival in all patients. In contrast, there were only 3 death cases in the study by Sun et al.1 This huge gap between 3 and 120 death cases could not have yielded reliable statistical results, because these predictor logistic regression analysis models were severely overfitted.Moreover, we were curious about the selection criteria of these variables in the predictor logistic regression analyses used in the Sun et al1 cohort study. Selecting the variables at random will result in inaccurate results. Potential variables or predictors are usually found by comparison between the deceased group and the alive group, then using these potential predictors for the subsequent predictor logistic regression analysis, so that more accurate results can be obtained.In this letter, I point out a statistical pitfall that results in inaccurate results. However, we congratulate and show great respect for the outstanding work of Sun et al.

Authors

Institutions

Publication Details

Journal
Archives of Pathology & Laboratory Medicine
Published
2025-01-27
DOI
https://doi.org/10.5858/arpa.2024-0181-le
Primary Topic
Cancer Cells and Metastasis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Presence of Small-Size Circulating Tumor Cells Predicts Worse Prognosis in Non–Small Cell Lung Cancer Patients

Jinghong Li, Xianxian Fu
Archives of Pathology & Laboratory Medicine
Cancer Cells and Metastasis
article

The Presence of Small-Size Circulating Tumor Cells Predicts Worse Prognosis in Non–Small Cell Lung Cancer Patients

Jinghong Li, Xianxian Fu
article en

Abstract

To the Editor.—Most non–small cell lung cancer (NSCLC) patients are diagnosed at advanced stages. The 5-year survival rate of patients with advanced lung cancer is less than 20%, which makes lung cancer the leading cause of cancer-related deaths worldwide. Thus, accurately predicting the prognosis of these patients is extremely important in clinics, and it could be a challenge for laboratories to determine a predictor of disease severity. In a recent issue of the Archives of Pathology & Laboratory Medicine, Sun et al1 aimed to find the association between circulating tumor cells, circulating tumor-derived endothelial cells and their subtypes, and the prognosis of NSCLC patients. Based on univariate and multivariate analysis, they found that small-size circulating tumor cells are a reliable prognostic indicator and a probable predictor of the severity of disease in NSCLC patients. However, in this letter, we raise some statistical concerns about this study that may change the results or conclusion.For the predictor logistic regression analysis in 2 previous studies, 10 outcomes for 1 variable were demanded as a basic statistical rule.2,3 However, in the study by Sun et al,1 Table 3 analyzed 12 variables, demanding 120 death cases, for the univariate analysis of survival in all patients. In contrast, there were only 3 death cases in the study by Sun et al.1 This huge gap between 3 and 120 death cases could not have yielded reliable statistical results, because these predictor logistic regression analysis models were severely overfitted.Moreover, we were curious about the selection criteria of these variables in the predictor logistic regression analyses used in the Sun et al1 cohort study. Selecting the variables at random will result in inaccurate results. Potential variables or predictors are usually found by comparison between the deceased group and the alive group, then using these potential predictors for the subsequent predictor logistic regression analysis, so that more accurate results can be obtained.In this letter, I point out a statistical pitfall that results in inaccurate results. However, we congratulate and show great respect for the outstanding work of Sun et al.

Archives of Pathology & Laboratory MedicineVol. 149(2)
Central South University (CN), Kunming Medical University (CN), Haikou City People's Hospital (CN), Yan'an Hospital Affiliated To Kunming Medical University (CN)
Openalex Percentile: Top 98%
Cancer Cells and Metastasis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.